Casdin Capital, LLC - SINGULAR GENOMICS SYSTEMS IN ownership

SINGULAR GENOMICS SYSTEMS IN's ticker is OMIC and the CUSIP is 82933R100. A total of 49 filers reported holding SINGULAR GENOMICS SYSTEMS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of SINGULAR GENOMICS SYSTEMS IN
ValueSharesWeighting
Q3 2023$504,400
-54.8%
1,323,885
-1.6%
0.06%
-42.9%
Q2 2023$1,116,949
-31.4%
1,345,7220.0%0.10%
-26.9%
Q1 2023$1,628,324
-39.8%
1,345,7220.0%0.13%
-36.2%
Q4 2022$2,704,901
-19.6%
1,345,7220.0%0.21%
-5.0%
Q3 2022$3,364,000
+1.7%
1,345,722
+55.4%
0.22%
-21.1%
Q2 2022$3,307,000
-63.7%
865,722
-40.0%
0.28%
-31.4%
Q1 2022$9,105,000
-45.4%
1,442,8700.0%0.41%
-13.2%
Q4 2021$16,680,000
-44.6%
1,442,870
-46.4%
0.47%
-37.3%
Q3 2021$30,133,000
-59.3%
2,692,8700.0%0.75%
-60.1%
Q2 2021$74,000,0002,692,8701.88%
Other shareholders
SINGULAR GENOMICS SYSTEMS IN shareholders Q3 2023
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 3,798,926$7,635,8411.96%
Tikvah Management LLC 316,854$636,8770.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,450,871$12,966,2510.27%
Triatomic Management LP 155,411$312,3760.26%
Casdin Capital, LLC 1,345,722$2,704,9010.21%
Perceptive Advisors 3,282,275$6,597,3730.18%
Oasis Management Co Ltd. 221,729$445,6750.09%
PLATINUM INVESTMENT MANAGEMENT LTD 881,068$1,770,9470.07%
Anson Funds Management LP 169,747$341,1910.06%
Weil Company, Inc. 53,202$106,9360.05%
View complete list of SINGULAR GENOMICS SYSTEMS IN shareholders